Demographic factors associated with missed follow-up among solid tumor patients treated at a large multi-site academic institution

Papers of special note have been highlighted as: • of interest

References

• 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J. Clin. 68(1), 7–30 (2018).
  MedlineGoogle Scholar
• 2. Brandenbarg D, Berendsen AJ, de Bock GH. Patients’ expectations and preferences regarding cancer follow-up care. Maturitas 105, 58–63 (2017).
  Medline CASGoogle Scholar
• 3. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J. Clin. Oncol. 13(5), 1144–1151 (1995).
  Medline CASGoogle Scholar
• 4. Geurts YM, Witteveen A, Bretveld R et al. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Res. Treat. 165(3), 709–720 (2017).
  Medline CASGoogle Scholar
• 5. Ryuk JP, Choi GS, Park JS et al. Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection. Ann. Surg. Treat. Res. 86(3), 143–151 (2014).
  MedlineGoogle Scholar
• 6. Molina-Montes E, Requena M, Sanchez-Cantalejo E et al. Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol. Oncol. 136(1), 158–171 (2015).
  MedlineGoogle Scholar
• 7. Oeffinger KC, Baxi SS, Novetsky Friedman D, Moskowitz CS. Solid tumor second primary neoplasms: who is at risk, what can we do? Semin. Oncol. 40(6), 676–689 (2013).
  MedlineGoogle Scholar
• 8. van der Sangen MJ, Poortmans PM, Scheepers SW et al. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer. Eur. J. Surg. Oncol. 39(8), 892–898 (2013).
  MedlineGoogle Scholar
• 9. Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res. Treat. 114(3), 403–412 (2009).
  Medline CASGoogle Scholar
• 10. Fujiya K, Tokunaga M, Makuuchi R et al. Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer. Gastric Cancer 20(Suppl. 1), 141–149 (2017).
  MedlineGoogle Scholar
• 11. Fiorillo CE, Hughes AL, I-Chen C et al. Factors associated with patient no-show rates in an academic otolaryngology practice. Laryngoscope 128(3), 626–631 (2018).
  MedlineGoogle Scholar
• 12. Shuja A, Harris C, Aldridge P, Malespin M, de Melo SW Jr. Predictors of no-show rate in the GI endoscopy suite at a safety net academic medical center. J. Clin. Gastroenterol. 53(1), 29–33 (2019).
  MedlineGoogle Scholar
• 13. Odonkor CA, Christiansen S, Chen Y et al. Factors associated with missed appointments at an academic pain treatment center: a prospective year-long longitudinal study. Anesth. Analg. 125(2), 562–570 (2017).
  MedlineGoogle Scholar
• 14. Boos EM, Bittner MJ, Kramer MR. A profile of patients who fail to keep appointments in a veterans affairs primary care clinic. WMJ. 115(4), 185–190 (2016).
  MedlineGoogle Scholar
• 15. Miller AJ, Chae E, Peterson E, Ko AB. Predictors of repeated ‘no-showing’ to clinic appointments. Am. J. Otolaryngol. 36(3), 411–414 (2015).
  MedlineGoogle Scholar
• 16. Kaplan-Lewis E, Percac-Lima S. No-show to primary care appointments: why patients do not come. J. Prim. Care Community Health 4(4), 251–255 (2013).
  MedlineGoogle Scholar
• 17. Karter AJ, Parker MM, Moffet HH et al. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med. Care 42(2), 110–115 (2004).
  MedlineGoogle Scholar
• 18. Cronin PR, Decoste L, Kimball AB. A multivariate analysis of dermatology missed appointment predictors. JAMA Dermatol. 149(12), 1435–1437 (2013).
  MedlineGoogle Scholar
• 19. Glover M, Daye D, Khalilzadeh O et al. Socioeconomic and demographic predictors of missed opportunities to provide advanced imaging services. J. Am. Coll. Radiol. 14(11), 1403–1411 (2017).
  MedlineGoogle Scholar
• 20. CDC. 2013 NCHS urban–rural classification scheme for counties. Vital Health Stat. 2(166), 1–81 (2014).
  Google Scholar
• 21. Massa ST, Rohde RL, McKinstry C et al. An assessment of patient burdens from head and neck cancer survivorship care. Oral Oncol. 82, 115–121 (2018). • This article highlights some of the financial, physical and emotional burdens of cancer survivorship care or patients with head and neck cancer.
  MedlineGoogle Scholar
• 22. Palmer NR, Geiger AM, Lu L, Case LD, Weaver KE. Impact of rural residence on forgoing healthcare after cancer because of cost. Cancer Epidemiol. Biomarkers Prev. 22(10), 1668–1676 (2013). • Rural patients likely have to travel further for follow up and survivorship; this can lead to some patients foregoing follow up care.
  MedlineGoogle Scholar
• 23. Siddika A, Tolia-Shah D, Pearson TE, Richardson NG, Ross AH. Remote surveillance after colorectal cancer surgery: an effective alternative to standard clinic-based follow-up. Colorectal Dis. 17(10), 870–875 (2015). • Remote follow-up could significantly improve adherence and reduce the burden on patients. This article highlights one potential system of remote follow-up for patients with colorectal cancer.
  Medline CASGoogle Scholar
• 24. Denis F, Lethrosne C, Pourel N et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J. Natl. Cancer Inst. 109(9), djx029 (2017).
  Google Scholar
• 25. Peipins LA, Graham S, Young R, Lewis B, Flanagan B. Racial disparities in travel time to radiotherapy facilities in the Atlanta metropolitan area. Soc. Sci. Med. 89, 32–38 (2013).
  MedlineGoogle Scholar
• 26. Benard VB, Johnson CJ, Thompson TD et al. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer 113(Suppl. 10), 2910–2918 (2008).
  MedlineGoogle Scholar
• 27. Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus–associated cancers – United States, 1999–2015. MMWR Morb. Mortal. Wkly. Rep. 67, 918–924 (2018).
  MedlineGoogle Scholar
• 28. Conway DI, Brenner DR, McMahon AD et al. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int. J. Cancer 136(5), 1125–1139 (2015).
  Medline CASGoogle Scholar
• 29. Harley AE, Yang M, Stoddard AM et al. Patterns and predictors of health behaviors among racially/ethnically diverse residents of low-income housing developments. Am. J. Health Promot. 29(1), 59–67 (2014).
  MedlineGoogle Scholar
• 30. Walsh B, O’Neill C. Socioeconomic disparities across ethnicities: an application to cervical cancer screening. Am. J. Manag. Care 21(9), e527–e536 (2015).
  MedlineGoogle Scholar
• 31. Mahal BA, Inverso G, Aizer AA, Bruce Donoff R, Chuang SK. Impact of African-American race on presentation, treatment, and survival of head and neck cancer. Oral Oncol. 50(12), 1177–1181 (2014).
  MedlineGoogle Scholar
• 32. Repka MC, Aghdam N, Karlin AW, Unger KR. Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting. Cancer Med. 6(11), 2497–2506 (2017).
  Medline CASGoogle Scholar
• 33. Celie KB, Jackson C, Agrawal S et al. Socioeconomic and gender disparities in anal cancer diagnosis and treatment. Surg. Oncol. 26(2), 212–217 (2017).
  MedlineGoogle Scholar
• 34. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101(5), 1051–1057 (2004).
  MedlineGoogle Scholar
• 35. Percac-Lima S, López L, Ashburner JM, Green AR, Atlas SJ. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer 120(13), 2025–2031 (2014).
  MedlineGoogle Scholar
• 36. Genoff MC, Zaballa A, Gany F et al. Navigating language barriers: a systematic review of patient navigators' impact on cancer screening for limited English proficient patients. J. Gen. Intern. Med. 31(4), 426–434 (2016).
  MedlineGoogle Scholar
• 37. Luckett R, Pena N, Vitonis A, Bernstein MR, Feldman S. Effect of patient navigator program on no-show rates at an academic referral colposcopy clinic. J. Womens Health 24(7), 608–615 (2015).
  Google Scholar
• 38. Syed ST, Gerber BS, Sharp LK. Traveling towards disease: transportation barriers to health care access. J. Community Health 38(5), 976–993 (2013).
  MedlineGoogle Scholar
• 39. Locatelli SM, Sharp LK, Syed ST, Bhansari S, Gerber BS. Measuring health-related transportation barriers in urban settings. J. Appl. Meas. 18(2), 178–193 (2017).
  MedlineGoogle Scholar
• 40. Percac-Lima S, Grant RW, Green AR et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J. Gen. Intern. Med. 24(2), 211–217 (2009).
  MedlineGoogle Scholar
• 41. Taylor VM, Hislop TG, Jackson JC et al. A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J. Natl. Cancer Inst. 94(9), 670–677 (2002).
  MedlineGoogle Scholar
• 42. Marcus AC, Crane LA, Kaplan CP et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med. Care 30(3), 216–230 (1992).
  Medline CASGoogle Scholar
• 43. Percac-Lima S, Cronin PR, Ryan DP, Chabner BA, Daly EA, Kimball AB. Patient navigation based on predictive modeling decreases no-show rates in cancer care. Cancer 121(10), 1662–1670 (2015).
  MedlineGoogle Scholar